FDA to ‘rapidly work’ towards emergency use authorization for Pfizer-BioNTech vaccine

Truman Slate

The Foods and Drug Administration said right now that subsequent yesterday’s good advisory committee assembly outcome about the Pfizer-BioNTech COVID-19 vaccine, it would fast perform towards finalization and issuance of an emergency use authorization for the COVID-19 vaccine. 

The Fda gave no precise timeline.

The agency has also notified the U.S. Centers for Illness Command and Avoidance and Operation Warp Pace, so they can execute their designs for well timed vaccine distribution.

HIMSS20 Electronic

Understand on-demand from customers, receive credit rating, uncover products and alternatives. Get Started >>

Approval usually means vaccine distribution would be on Operation Warp Speed’s program for distribution to entrance-line healthcare staff and susceptible populations in lengthy-term treatment amenities by mid-month.

The Fda advisory committee has scheduled yet another assembly to review the Moderna vaccine on Thursday, December seventeen.

See our continuing vaccine coverage right here:

Pfizer-BioNTech vaccine gets Fda advisory committee approval

CMS provides assistance in billing Medicare for COVID-19 antibody procedure

Hundreds in the United Kingdom are the initial to acquire Pfizer COVID-19 vaccine

Eli Lilly and UnitedHealth Group lover on COVID-19 antibody procedure for higher-hazard individuals

Operation Warp Pace is looking to start off distributing COVID-19 vaccine by mid-month

Moderna seeks regulatory authorization for its COVID-19 vaccine

HHS will start off allocating Regeneron’s COVID-19 therapeutic this 7 days

HHS associates with chain and independent pharmacies to boost obtain to long term COVID-19 vaccines

COVID-19 vaccine distribution will start off inside 24 several hours of an emergency use authorization

Moderna vaccine applicant exhibits 94.5{d5f2c26e8a2617525656064194f8a7abd2a56a02c0e102ae4b29477986671105} efficacy towards COVID-19

Pfizer touts new COVID-19 vaccine, calling it ’90{d5f2c26e8a2617525656064194f8a7abd2a56a02c0e102ae4b29477986671105} effective’

Medicare beneficiaries can get monoclonal antibody COVID-19 treatment plans at no value

Fda grants emergency use authorization for Eli Lilly antibody procedure for COVID-19

Twitter: @SusanJMorse
Electronic mail the author: [email protected]

Next Post

New interoperability rules address prior authorization inefficiencies, CMS says

The Centers for Medicare and Medicaid Products and services has proposed a new rule that seeks to streamline prior authorizations to lighten clinician workload and make it possible for them more time to see sufferers. In theory, the rule would boost the digital trade of healthcare data among payers, providers […]